Subsequent malignancies and their effect on survival in patients with retinoblastoma

Pediatric Blood and Cancer

Volumn 61, Issue 1, 2014, Pages 116-119

  Shinohara, Eric T ^a   DeWees, Todd ^b   Perkins, Stephanie M ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Retinoblastoma; Secondary malignancy; SEER

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOCARCINOMA; ADOLESCENT; ADULT; ARM; ARTICLE; BLADDER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CRYOTHERAPY; ENUCLEATION; FACE; FEMALE; FOLLOW UP; HUMAN; LEG; LEIOMYOSARCOMA; LIPOSARCOMA; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; MULTIMODALITY CANCER THERAPY; NEUROFIBROMA; ORBIT; OSTEOSARCOMA; OVERALL SURVIVAL; PELVIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RHABDOMYOSARCOMA; SCHOOL CHILD; SCROTUM; SECOND CANCER; STANDARDIZED INCIDENCE RATIO; STANDARDIZED MORTALITY RATIO; SUBSEQUENT MALIGNANT NEOPLASM; SURVIVAL RATE; SURVIVAL TIME; TUMOR ABLATION; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CARCINOMA; YOUNG ADULT; ADVERSE OUTCOME; BILATERAL CANCER; CANCER PATIENT; COHORT ANALYSIS; HIGH RISK PATIENT; RISK ASSESSMENT; COMPLICATION; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINAL NEOPLASMS; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84891676631     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24714     Document Type: Article

References (16)

1. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 2009;93:24-27.
2. Fontanesi J, Taub J, Kirkpatrick J, et al. Retinoblastoma. In: Halperin E, Constine L, Tarbell N, et al., editors. Pediatric radiation oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. pp 85-107.
3. Dimaras H, Kimani K, Dimba EA, et al. Retinoblastoma. Lancet 2012;379:1436-1446.
4. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646.
5. Knudson AG, Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
6. Richter S,Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003;72:253-269.
7. Kleinerman RA, Tucker MA, Abramson DH, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 2007;99:24-31.
8. Cavenee WK, Murphree AL, Shull MM, et al. Prediction of familial predisposition to retinoblastoma. N Engl J Med 1986;314:1201-1207.
9. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121-1128.
10. Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEERz.ast;Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2011 Sub (1973-2009) -Linked To County Attributes-Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS. Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
11. Rothman K, Boice J. Epidemiologic analysis with a programmable calculator. Bethesda, Maryland: NIH Publications No. 79-1649; 1979; pp 31-32.
12. Breslow N, Day N. Fitting models to grouped data. Lyon, France: IARC Scientific Publications No. 82; 1987.
13. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2005 incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2009.
14. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154.
15. Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol 2012;30:950-957.
16. Wong FL, Boice JD, Jr., Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278:1262-1267.